IDXX: יחס שווי פעילות לרווח לפני ריבית, מסים ופחת IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. (IDXX) solutions establish a global benchmark for evidence-based veterinary medicine, demonstrating structural growth. A team of elite scientists, united by a strong ethic and mission, drives this success. The company's EV/EBITDA ratio on this chart clearly captures market expectations, with the 33.65 level serving as a critical mark. High business margins are based on recurring consumable sales and the expansion of the analyzer install base.

Investors are verifying the issuer's resilience through the ratio of enterprise value to earnings before interest, taxes, depreciation, and amortization. The current EV/EBITDA multiple for IDEXX Laboratories, Inc. (IDXX) on the GURU.Markets platform measures the payback period for all assets, including debt. For IDEXX Laboratories, Inc. (IDXX), this indicator confirms the effectiveness of implementing AI diagnostics in veterinary medicine. A downward trend on this chart signals that the high-tech business is undervalued, opening a window for discounted purchases.